ARTICLE | Company News
Provalis, Medical Marketing deal
October 15, 2001 7:00 AM UTC
Medical Marketing received exclusive rights to develop PRO’s CCX2 plant-derived cancer therapy. Medical Marketing said that in a mouse xenograft model of ovarian cancer, CCX2 stopped the growth of hum...